Recall for the Preparation Rafassal 500 MG
Rafa Co., the manufacturer and marketer of Rafassal 500 mg caplets, announces, in coordination with the Ministry of Health, the recall for this product over concerns due to changes to…
Rafa Co., the manufacturer and marketer of Rafassal 500 mg caplets, announces, in coordination with the Ministry of Health, the recall for this product over concerns due to changes to…
Learn how to protect against mosquito bites in Israel with effective strategies for controlling mosquitoes indoors and outdoors, using repellents, and wearing protective clothing.
Sixth pediatric flu death in Israel this year as a healthy two-month-old dies. Ministry urges vaccination for indirect protection & masks for at-risk.
Israel's Health Committee prioritizes IDF veterans for medical residency, as Palestinian graduates from Nablus and East Jerusalem universities training in.
Israeli researchers reveal sleep's ancient purpose, dating back to jellyfish, is vital for nerve cell protection. Improving sleep quality may slow Alzheimer's.
An Israeli State Comptroller report warns over 10,000 hospital beds (56%) lack protection from rocket attacks, endangering patients and staff across Israel's.
Brain synchronization predicts mental resilience, a Haifa study reveals. Stronger social synchrony reduces post-traumatic stress after Oct 7.
Israel's Ministry of Agriculture and Israel Land Authority will establish therapeutic farms on agricultural lands for PTSD sufferers, at-risk youth.
Rabies infected sheep found near Ghajar village in Upper Galilee; five people exposed and referred for preventive treatment.
Israel confirms its first H5N1 avian flu outbreak of the 2025-26 season in commercial poultry, affecting 2,000 ducks in Moshav Sde Yaakov. A 10km quarantine.
An Israeli biotech breakthrough from the Weizmann Institute of Science allows doctors to track immunity to new viruses in minutes, crucial for future pandemic.
Israeli scientists from Tel Aviv University made a breakthrough, discovering how breast cancer adapts to the brain, paving the way for new treatments for 10-15%.